Using a Patient's own cells to fight back against leukemia
NCT ID NCT00534469
Summary
This study tested a treatment for adults with a type of blood cancer called acute myeloid leukemia (AML) who were in their first remission. Doctors collected the patient's own blood-forming stem cells, gave high-dose chemotherapy and radiation to wipe out remaining cancer cells, and then returned the stored stem cells to rebuild the immune system. After the transplant, patients received a drug (aldesleukin) intended to help prevent the cancer from returning.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LEUKEMIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.